Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVAPRITINIB vs AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE OR AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AVAPRITINIB vs AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE OR AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE: Safety Overview

Metric AVAPRITINIB AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE OR AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE
Total FAERS Reports 10,117 111
Deaths Reported 302 2
Death Rate 3.0% 1.8%
Hospitalizations 942 9
Average Patient Age 62.4 yrs 38.1 yrs
% Female Patients 56.5% 71.8%
FDA Approval Date Jan 9, 2020 N/A
Manufacturer Blueprint Medicines Corporation N/A
Route ORAL N/A
Marketing Status Prescription N/A